Jeffrey I. Gordon
Jeffrey Ivan Gordon | |
---|---|
Born | c. 1947 (age 76–77) |
Nationality | American |
Alma mater | University of Chicago Oberlin College |
Awards | Copley Medal (2018) Balzan Prize (2021) |
Scientific career | |
Fields | Medicine |
Institutions | Washington University in St. Louis |
Jeffrey Ivan Gordon
Education and early career
Gordon received his bachelor's degree in Biology at 1969 at Oberlin College in Ohio. Over the next four years, Gordon received his medical training at the University of Chicago and graduated with honors in 1973. After two years as intern and junior assistant resident in Medicine at Barnes Hospital, St Louis, Gordon joined the Laboratory of Biochemistry at the National Cancer Institute as a Research Associate in 1975. He returned to Barnes Hospital in 1978 to become Senior Assistant Resident and then Chief Medical Resident at Washington University Medical Service. In 1981 he completed a fellowship in medicine (Gastroenterology) at Washington University School of Medicine. In the following years, Gordon rose quickly through the academic ranks at Washington University: Asst. Prof. (1981–1984); Assoc. Prof. (1985–1987); Prof. (1987–1991) of Medicine and Biological Chemistry. In 1991, he became head of the Dept. Molecular Biology & Pharmacology (1991–2004). Gordon is currently the Director of the Center for Genome Sciences (2004–present) at Washington University in St. Louis.
Gordon's early career focused on the development of cell lineages within the
Gordon played a pivotal role in the study of protein N-myristoylation, a co-translational modification by which a myristoyl group is covalently attached to an N-terminal glycine residue of a nascent polypeptide. Gordon and his colleagues were instrumental in characterizing the mechanism by which N-myristoyltransferase (the enzyme that catalyzes the myristoylation reaction) selects its substrates and its catalytic mechanism.[5]
Gordon's group published a series of elegant studies that describe the ability of components of the commensal microbiota to induce specific responses in the host intestinal epithelium. One of these responses, the induction of intestinal cell surface fucose residues, is elicited by a prominent human intestinal symbiont, Bacteroides thetaiotaomicron, which can harvest and use the host fucose as a carbon and energy source.[6] Gordon's group published a seminal study in which functional genomics were used to document the genome-wide intestinal epithelial response to microbial colonization of the gastrointestinal tract.[7] Dr. Gordon's laboratory has investigated epithelial cell interaction with human-associated pathogens, including uropathogenic Escherichia coli, Helicobacter pylori, and Listeria monocytogenes.
Present research
Gordon and his laboratory are currently focused on understanding the mutualistic interactions that occur between humans and the 10–100 trillion commensal microbes that colonize each person's gastrointestinal tract. To tease apart the complex relationships that exist within this gut microbiota, Dr. Gordon's research program employs
Gordon has become an international pioneer in the study of gut microbial ecology and evolution, using innovative methods to interpret
Gordon is the lead author of an influential 2005
Selected honors
- 1973 M.D. with honors; Alpha Omega Alpha; Upjohn Achievement Award
- 1989 Membership, Association of American Physicians
- 1990 American Federation Clinical Research Young Investigator Award
- 1990 NIDDK Young Scientist Award
- 1992 Am. Gastroenterology Association Distinguished Achievement Award
- 1992 Fellow, American Association for the Advancement of Science
- 1991–1994 Distinguished Service Teaching Awards, Washington University School of Medicine
- 1994 Marion Merrell Dow Distinguished Prize in Gastrointestinal Physiology
- 1998 Wellcome Visiting Professor in the Basic Medical Sciences
- 2001 Fellow, American Academy of Microbiology
- 2001 Elected, National Academy of Sciences
- 2002 Dr. Robert J. Glaser Distinguished University Professorship
- 2003 Janssen Sustained Achievement Award in Digestive Sciences
- 2003 Senior Scholar Award in Global Infectious Diseases, The Ellison Medical Foundation
- 2004 Member, American Academy of Arts & Sciences
- 2005 ASM Lecturer, American Society of Microbiology
- 2008 Elected, Institute of Medicine, National Institute of Sciences
- 2013 Selman A. Waksman Award in Microbiology
- 2013 Robert Koch Prize
- 2014 Passano Award
- 2014 Elected, American Philosophical Society
- 2014 Dickson Prize
- 2014 Howard Taylor Ricketts Award
- 2015 King Faisal International Prizein Medicine
- 2015 Keio Medical Science Prize
- 2016 Steven C. Beering Award, Indiana University
- 2017 Jacobaeus Prize, Novo Nordisk Foundation
- 2017 Massry Prize
- 2017 Louisa Gross Horwitz Prize[15]
- 2018 Copley Medal[15]
- 2018 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine
- 2021 Balzan Prize for Microbiome in Health and Disease[16]
- 2023 Princess of Asturias Awards[17]
- 2023 Albany Medical Center Prize[18]
References
- ^ Akademien
- ^ "Lab of Jeffrey I. Gordon • 2017 • Washington University in St. Louis". Archived from the original on August 7, 2019. Retrieved September 30, 2011.
- ^ "Washington University News". Archived from the original on June 8, 2010. Retrieved February 19, 2008.
- ^ "APS Member History". search.amphilsoc.org. Retrieved March 12, 2021.
- ISSN 0021-9258.
- S2CID 39804775.
- PMID 11157169.
- PMID 17210919.
- S2CID 4400297.
- S2CID 205034045.
- S2CID 13588903.
- PMID 17563350.
- PMID 18005754.
- ^ NIH Roadmap Archived December 10, 2010, at the Wayback Machine
- ^ a b "Gordon CV". Lab of Jeffrey I. Gordon. June 26, 2020. Retrieved February 23, 2021.
- ^ "Jeffrey I. Gordon". www.balzan.org. Retrieved April 13, 2022.
- ^ Princess of Asturias Awards 2023
- ^ Albany Medical Center Prize 2023